首页 > 市场调查报告书 > 医疗设备

药物递输设备

市场调查报告书

商品编码

1575720

全球输液治疗市场 - 2024-2031

Global Infusion Therapy Market - 2024-2031

出版日期: 2024年10月22日 | 出版商:

DataM Intelligence | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

全球输液治疗市场在 2023 年达到 435 亿美元，预计到 2031 年将达到 737 亿美元，2024-2031 年预测期间复合年增长率为 6.8%。

输液疗法也称为静脉注射 (IV) 疗法，是一种涉及透过针或导管将药物、液体或营养物质直接输送到患者血液中的医疗程序。此方法主要用于为各种医疗状况提供即时有效的治疗。

输注疗法是比口服药物更安全的替代方案，特别是对于吞嚥困难的患者。在胃酸可能会损害某些药物的有效性、降低其疗效的情况下，它也很有用。输液治疗对于管理需要精确剂量和不间断给药的医疗状况至关重要。持续、准确地输送药物的能力对于有效治疗各种健康问题至关重要。

市场动态：

司机

慢性病盛行率上升和技术进步

全球输液治疗市场的需求是由多种因素所驱动的。主要因素之一是慢性病盛行率上升和技术进步。糖尿病、癌症和心血管疾病等慢性病发病率的上升极大地推动了输液治疗市场的发展。这些疾病通常需要长期管理和精确的药物输送，这使得输液疗法变得越来越重要。

根据世界卫生组织（WHO）2024年的资料，心血管疾病是全球主要死亡原因，每年约导致1,790万人死亡。输液治疗在治疗心臟衰竭等疾病方面发挥着至关重要的作用，持续的药物传递对于实现最佳患者治疗效果至关重要。

输液设备的创新，特别是与电子健康记录 (EHR) 整合以进行即时监控的智慧型输液帮浦的开发，正在显着提高患者的安全和治疗效果。这些进步正在改变输液治疗的格局，使其更有效率且用户友好，这将推动市场成长。

此外，该行业技术进步的关键参与者（例如引入慢性病创新疗法和推出先进软体）推动了该市场的成长。例如，2024 年 2 月，NHS 推出了一种治疗晚期帕金森氏症的新疗法，称为 foslevodopa-foscarbidopa，也称为 Produodopa。这种创新疗法专为传统口服药物无法充分控制症状的患者而设计。它涉及一个便携式、可穿戴的输液系统，透过佩戴在皮下的小泵持续输送药物，从而实现 24 小时症状管理。

同样，2023 年 6 月，B. Braun Medical Inc. 推出了最新的输液管理软体 DoseTrac Enterprise Infusion Management Software，旨在加强医疗机构内输液帮浦的管理。这种先进的软体提供了即时监控和回顾性报告功能的组合，使组织能够更深入地了解其输液帮浦组和相关资料。

限制

先进技术的高成本、设备的风险和复杂性以及监管和报销挑战等因素预计将阻碍市场的发展。

细分市场分析

全球输液治疗市场根据产品类型、给药途径、应用、最终用户和地区进行细分。

输液帮浦领域约占全球输液治疗市占率的52.1%

预计输液帮浦领域在预测期内将占据最大的市场份额。对准确、高效的药物输送系统的需求不断增长，导致输液泵的使用增加。这些设备专门设计用于以规定剂量向患者输送液体、药物或营养物质，这使得它们对于广泛的医疗应用至关重要。

输液帮浦领域的特点是不断的技术进步，显着提高了病患的安全和治疗效果。最引人注目的创新之一是智慧型输液帮浦的开发，它与电子健康记录 (EHR) 无缝集成，以方便即时监控患者资料。

整合电子健康记录 (EHR) 的智慧输液帮浦可最大限度地降低用药错误的风险，从而显着提高病患安全。该技术允许将药物订单直接从 EHR 自动传输到输液泵，无需手动编程并减少人为错误的可能性。

此外，行业主要参与者的产品发布和输液泵的关键发展正在推动该细分市场的成长。例如，2023年2月，迈瑞推出了BeneFusion i系列和u系列输液系统，标誌着输液技术的重大进步，强调高精度、自适应定制和用户友好的介面，以提高各种临床环境中的用药安全性。这项发展符合采用智慧输液帮浦的日益增长的趋势，智慧输液帮浦已从基本的机械设备发展到旨在最大限度地减少用药错误并改善患者治疗效果的复杂系统。

同样，2023 年 4 月，Eitan Medical 推出了 Avoset 输液系统，这是一种尖端的连接动态输液泵，旨在增强急性后护理和专业输液治疗。该创新系统致力于透过其紧凑的设计和先进的技术来提高患者安全和用户体验。

市场地理分析

北美约占全球输液治疗市占率的44.6%

由于癌症、糖尿病和心血管疾病等慢性疾病发病率的增加，显着推动了北美对输液治疗的需求，预计北美地区将在预测期内占据最大的市场份额。

据美国癌症协会称，2021年美国新诊断出约190万癌症病例。的需求增加。

同样，美国医院协会表示，美国约有 1.33 亿人（近一半人口）患有至少一种慢性病，如高血压、心臟病或关节炎。到 2030 年，这一数字预计将增至约 1.7 亿，凸显慢性病对该国医疗保健系统带来的负担日益加重。

此外，在该地区，大量关键参与者的存在、先进的医疗基础设施、技术进步、政府优惠的报销政策、对家庭医疗服务、产品发布和审批不断增长的需求将推动该市场的成长。

例如，2024 年 4 月，Mackenzie Health 在加拿大推出了 BD Alaris EMR 互通性系统，代表了静脉 (IV) 药物管理的重大进步。这项创新技术可实现静脉输液帮浦与病患电子病历 (EMR) 之间的双向通信，从而简化输液流程并提高病患安全。

此外，2024 年 4 月，Baxter International Inc. 的配备 Dose IQ 安全软体的 Novum IQ 大容量输液帮浦 (LVP) 获得了 FDA 510(k) 许可。 Novum IQ 输液平台已包含注射器输液帮浦 (SYR)，这项新增功能使医疗保健提供者能够在各种病患照护环境中使用统一的系统。 Novum IQ 平台透过整合 LVP 和 SYR 帮浦增强了使用者体验，从而减轻了临床医生非关键任务的工作量。这种整合有助于简化培训过程，并减少与管理多个泵浦系统相关的认知负担。

Infusion therapy, also known as intravenous (IV) therapy, is a medical procedure that involves delivering medications, fluids, or nutrients directly into a patient's bloodstream through a needle or catheter. This method is primarily used to provide immediate and effective treatment for various medical conditions.

Infusion therapy serves as a safer alternative to oral medication, particularly for patients who have difficulty swallowing. It is also beneficial in situations where stomach acids could compromise the effectiveness of certain medications, rendering them less effective. Infusion therapy is crucial for managing medical conditions that necessitate precise dosing and uninterrupted medication administration. The ability to deliver medications continuously and accurately is vital for effectively treating various health issues.

Market Dynamics: Drivers

Rising prevalence of chronic diseases and technological advancements

The demand for the global infusion therapy market is driven by multiple factors. One of the primary factors is the rising prevalence of chronic diseases and technological advancements. The rising incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases significantly drives the infusion therapy market. These diseases often require long-term management and precise medication delivery, which makes infusion therapies increasingly essential.

According to the World Health Organization (WHO) data in 2024, indicates that cardiovascular diseases are the leading cause of death worldwide, responsible for approximately 17.9 million fatalities each year. Infusion therapy plays a vital role in managing conditions like heart failure, where continuous medication delivery is essential for achieving optimal patient outcomes.

Innovations in infusion devices, particularly the development of smart infusion pumps that integrate with electronic health records (EHRs) for real-time monitoring, are significantly enhancing patient safety and treatment efficacy. These advancements are transforming the landscape of infusion therapy, making it more efficient and user-friendly, which would propel market growth.

Moreover, key players in the industry's technological advancements such as the introduction of innovative treatments for chronic diseases and launching advanced software propel this market growth. For instance, in February 2024, the NHS launched a new treatment for advanced Parkinson's disease known as foslevodopa-foscarbidopa, also referred to as Produodopa. This innovative therapy is designed for patients whose symptoms are not adequately managed by traditional oral medications. It involves a portable, wearable infusion system that continuously delivers medication through a small pump worn under the skin, allowing for 24-hour symptom management.

Similarly, in June 2023, B. Braun Medical Inc. unveiled its latest infusion management software, DoseTrac Enterprise Infusion Management Software, aimed at enhancing the management of infusion pumps within healthcare organizations. This advanced software provides a combination of real-time monitoring and retrospective reporting capabilities, allowing organizations to gain deeper insights into their infusion pump fleet and the associated data.

Restraints

Factors such as the high cost of advanced technologies, risk & complexity of devices, and regulatory & reimbursement challenges are expected to hamper the market.

Market Segment Analysis

The global infusion therapy market is segmented based on product type, route of administration, application, end-user, and region.

The infusion pumps segment accounted for approximately 52.1% of the global infusion therapy market share

The infusion pumps segment is expected to hold the largest market share over the forecast period. The growing need for accurate and efficient medication delivery systems has led to a rise in the use of infusion pumps. These devices are specifically designed to administer fluids, medications, or nutrients to patients in regulated doses, making them crucial for a wide range of medical applications.

The infusion pumps segment is marked by ongoing technological advancements that significantly enhance patient safety and treatment effectiveness. One of the most notable innovations is the development of smart infusion pumps, which integrate seamlessly with electronic health records (EHRs) to facilitate real-time monitoring of patient data.

Smart infusion pumps with electronic health record (EHR) integration offer a significant improvement in patient safety by minimizing the risk of medication administration errors. This technology allows for the automatic transmission of medication orders directly from the EHR to the infusion pump, eliminating the need for manual programming and reducing the potential for human error.

Moreover, key players in the industry product launches and key developments in the infusion pumps are driving this segment growth in the market. For instance, in February 2023, Mindray launched the BeneFusion i Series and u Series infusion systems marking a significant advancement in infusion technology, emphasizing high precision, adaptive customization, and user-friendly interfaces to enhance medication safety across various clinical settings. This development aligns with the growing trend of adopting smart infusion pumps, which have evolved from basic mechanical devices to sophisticated systems designed to minimize medication errors and improve patient outcomes.

Similarly, in April 2023, Eitan Medical introduced the Avoset Infusion System, a cutting-edge connected ambulatory infusion pump designed to enhance post-acute care and specialty infusion therapy. This innovative system focuses on improving patient safety and user experience through its compact design and advanced technology.

Market Geographical Analysis

North America accounted for approximately 44.6% of the global infusion therapy market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular conditions significantly driving the demand for infusion therapy in North America.

According to the American Cancer Society, around 1.9 million new cancer cases were diagnosed in the United States in 2021. Many individuals diagnosed with cancer require infusion therapy for treatments such as chemotherapy and other supportive care, which leads to an increased demand for related products and services.

Similarly, American Hospital Association, stated that around 133 million people in the United States, which is nearly half the population, suffer from at least one chronic condition, such as hypertension, heart disease, or arthritis. This number is expected to rise to approximately 170 million by the year 2030, underscoring the increasing burden that chronic diseases place on the healthcare system in the country.

Moreover, in this region, a major number of key player's presence, well-advanced healthcare infrastructure, technological advancements, government favorable reimbursement policies, growing demand for home healthcare services, product launches, and approvals would drive this market growth.

For instance, in April 2024, in Canada, Mackenzie Health's launch of the BD Alaris EMR Interoperability system represents a significant advancement in intravenous (IV) medication management. This innovative technology enables two-way communication between IV infusion pumps and the patient's electronic medical record (EMR), streamlining the infusion process and enhancing patient safety.

Also, in April 2024, Baxter International Inc. received FDA 510(k) clearance for its Novum IQ large volume infusion pump (LVP) equipped with Dose IQ Safety Software. This addition to the Novum IQ Infusion Platform, which already includes a syringe infusion pump (SYR), allows healthcare providers to utilize a unified system across various patient care environments. The Novum IQ platform enhances the user experience by integrating the LVP and SYR pumps, thereby alleviating the workload of non-critical tasks for clinicians. This integration facilitates a streamlined training process and reduces the cognitive load associated with managing multiple pump systems.

Market Segmentation

By Product Type

Infusion Pumps

Intravenous Sets

IV Cannulas

Needleless Connectors

Vein Imaging Devices

By Route of Administration

Intramuscular

Subcutaneous

Epidural

By Application

Antibiotic & Viral

Inotropic Therapy

Anti-coagulation

Chemotherapy

Nutritional Therapy

Blood Component

Others

By End-User

Hospitals & Specialty Clinics

Ambulatory Surgery Centers

Homecare Settings

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the infusion therapy market include B. Braun Melsungen AG, ICU Medical, Inc., Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Becton, Dickinson and Company, Nipro Corporation, Mindray Medical India Pvt. Ltd., Moog Inc., and Teleflex Incorporated among others.

Key Developments

In January 2024, AbbVie launched Produodopa (foslevodopa/foscarbidopa), a continuous subcutaneous infusion therapy, for the treatment of advanced Parkinson's disease in the European Union. Produodopa is the first and only 24-hour levodopa-based subcutaneous infusion therapy approved for this indication in the EU.

In June 2023, Eitan Medical introduced Eitan Insights, a new cloud-based infusion management system tailored for home and specialty infusion needs. This innovative platform connects with Eitan Medical's infusion systems, including the Sapphire pump, which now features a universal plug-and-play cellular accessory called Sapphire Connect, and the Avoset pump, complemented by the AvosetGo app.

Why Purchase the Report?

To visualize the global infusion therapy market segmentation based on product type, route of administration, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the infusion therapy market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global infusion therapy market report would provide approximately 70 tables, 68 figures, and 183 pages

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Route of Administration
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Prevalence of Chronic Diseases and Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Advanced Technologies
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Infusion Pumps *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Intravenous Sets
6.4. IV Cannulas
6.5. Needleless Connectors
6.6. Vein Imaging Devices

7. By Route of Administration

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 7.1.2. Market Attractiveness Index, By Route of Administration
7.2. Intramuscular *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Subcutaneous
7.4. Epidural

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Distribution Channels
8.2. Antibiotic & Viral *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Inotropic Therapy
8.4. Anti-coagulation
8.5. Chemotherapy
8.6. Nutritional Therapy
8.7. Blood Component
8.8. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals & Specialty Clinics *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgery Centers
9.4. Homecare Settings

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.4.9. Brazil
- 10.4.10. Argentina
- 10.4.11. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. B. Braun Melsungen AG*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. ICU Medical, Inc.
12.3. Baxter International Inc.
12.4. Fresenius Kabi AG
12.5. Terumo Corporation
12.6. Becton, Dickinson and Company
12.7. Nipro Corporation
12.8. Mindray Medical India Pvt. Ltd.
12.9. Moog Inc.
12.10. Teleflex Incorporated (*LIST NOT EXHAUSTIVE)

13. Appendix

13.1. About Us and Services
13.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球输液治疗市场 - 2024-2031

Global Infusion Therapy Market - 2024-2031

市场动态：

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：依产品类型

第 7 章：依给药途径分类

第 8 章：按申请

第 9 章：最终用户

第 10 章：按地区

第 11 章：竞争格局

第 12 章：公司简介

第 13 章：附录